HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,432: | Line 1,432: | ||
| | | | ||
|- | |- | ||
|Splenic diffuse red pulp small B-cell lymphoma||Disease|| || || || || ||SG|| || | |[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| || | ||
| | | | ||
|*Snehal Patel, MD, PhD | |*Snehal Patel, MD, PhD | ||
| Line 1,439: | Line 1,439: | ||
| | | | ||
|- | |- | ||
|Splenic B-cell lymphoma/leukaemia with prominent nucleoli | |[[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,455: | Line 1,455: | ||
| | | | ||
|- | |- | ||
|Lymphoplasmacytic lymphoma | |[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,471: | Line 1,471: | ||
| | | | ||
|- | |- | ||
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | |[[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,487: | Line 1,487: | ||
| | | | ||
|- | |- | ||
|Primary cutaneous marginal zone lymphoma | |[[HAEM5:Primary cutaneous marginal zone lymphoma|Primary cutaneous marginal zone lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,503: | Line 1,503: | ||
| | | | ||
|- | |- | ||
|Nodal marginal zone lymphoma | |[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,519: | Line 1,519: | ||
| | | | ||
|- | |- | ||
|Paediatric nodal marginal zone lymphoma | |[[HAEM5:Paediatric nodal marginal zone lymphoma|Paediatric nodal marginal zone lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,535: | Line 1,535: | ||
| | | | ||
|- | |- | ||
|In situ follicular B-cell neoplasm | |[[HAEM5:In situ follicular B-cell neoplasm|In situ follicular B-cell neoplasm]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,551: | Line 1,551: | ||
| | | | ||
|- | |- | ||
|Follicular lymphoma | |[[HAEM5:Follicular lymphoma|Follicular lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,567: | Line 1,567: | ||
| | | | ||
|- | |- | ||
|Paediatric-type follicular lymphoma | |[[HAEM5:Paediatric-type follicular lymphoma|Paediatric-type follicular lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,583: | Line 1,583: | ||
| | | | ||
|- | |- | ||
|Duodenal-type follicular lymphoma | |[[HAEM5:Duodenal-type follicular lymphoma|Duodenal-type follicular lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,599: | Line 1,599: | ||
| | | | ||
|- | |- | ||
|Primary cutaneous follicle centre lymphoma | |[[HAEM5:Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle centre lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,615: | Line 1,615: | ||
| | | | ||
|- | |- | ||
|In situ mantle cell neoplasm | |[[HAEM5:In situ mantle cell neoplasm|In situ mantle cell neoplasm]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,631: | Line 1,631: | ||
| | | | ||
|- | |- | ||
|Mantle cell lymphoma | |[[HAEM5:Mantle cell lymphoma|Mantle cell lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||